Showing results (2081-2090 of 2,349) with videos related to
Sort By:
Pageof 235
Journal of Hospital Medicine|April 16, 2015
Association between exposure to nonactionable physiologic monitor alarms and response time in a children's hospitalChristopher P Bonafide, Richard Lin, Miriam Zander, et al.Journal of the American Medical Informatics Association : JAMIA|January 14, 2026
Information extraction from clinical notes: are we ready to switch to large language models?Yan Hu, Xu Zuo, Yujia Zhou, et al.NPJ Parkinson'S Disease|July 14, 2018
Prevalence of Parkinson's disease across North AmericaC Marras, J C Beck, J H Bower, et al.Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|January 20, 2022
1,550 nm Erbium-Doped and 1,927 nm Thulium Nonablative Fractional Laser System: Best Practices and Treatment Setting RecommendationsPaul M Friedman, Jeffrey S Dover, Anne Chapas, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2014
Lyn deficiency leads to increased microbiota-dependent intestinal inflammation and susceptibility to enteric pathogensMorgan E Roberts, Jennifer L Bishop, Xueling Fan, et al.Journal of Drugs in Dermatology : JDD|April 11, 2014
Consensus recommendations on the use of injectable poly-L-lactic acid for facial and nonfacial volumizationDanny Vleggaar, Rebecca Fitzgerald, Z Paul Lorenc, et al.Molecular and Cellular Biology|January 1, 2004
BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1Brian Carpenter, Kathryn J Hill, Marika Charalambous, et al.Development Genes and Evolution|May 15, 2023
Duplicated zebrafish (Danio rerio) inositol phosphatases inpp5ka and inpp5kb diverged in expression pattern and functionDhyanam Shukla, Brian M Gural, Edmund S Cauley, et al.The American Surgeon|May 3, 2023
A Multidisciplinary Approach for the Management of Portal Vein ThrombosisKyle Sheppard, Morgan E Roberts, Jonathan Bernard, et al.British Journal of Pharmacology|March 19, 2016
Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activityF L Scott, B Clemons, J Brooks, et al.Pageof 235